In a new study, fixed-dose combination (FDC) of vildagliptin and dapagliflozin demonstrated substantial efficacy and good tolerability in managing Type 2 Diabetes Mellitus (T2DM). The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback